[1] |
Cheung CM, Chee SP. Posterior scleritis in children: clinical features and treatment. Ophthalmology 2012; 119(1):59-65. doi:10.1016/j.ophtha.2011.09.030.
doi: 10.1016/j.ophtha.2011.09.030
pmid: 22137553
|
[2] |
Yang PZ, Ye Z, Tang JH, et al. Clinical features and complications of scleritis in Chinese patients. Ocul Immunol Inflamm 2018; 26(3):387-96. doi:10.1080/09273948.2016.1241282.
doi: 10.1080/09273948.2016.1241282
pmid: 27849414
|
[3] |
Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 2000; 130(4):469-76. doi:10.1016/s0002-9394(00)00710-8.
doi: 10.1016/s0002-9394(00)00710-8
pmid: 11024419
|
[4] |
Homayounfar G, Borkar DS, Tham VM, et al. Clinical characteristics of scleritis and episcleritis: results from the pacific ocular inflammation study. Ocul Immunol Inflamm 2014; 22(5):403-4. doi:10.3109/09273948.2013.854394.
doi: 10.3109/09273948.2013.854394
pmid: 24295070
|
[5] |
Majumder PD, Ali S, George A, et al. Clinical Profile of Scleritis in Children. Ocul Immunol Inflamm 2019; 27:535-9. doi:10.1080/09273948.2017.1423333.
doi: 10.1080/09273948.2017.1423333
pmid: 29370565
|
[6] |
Majumder PD, Agrawal R, McCluskey P, et al. Current Approach for the Diagnosis and Management of Noninfective Scleritis. Asia Pac J Ophthalmol (Phila) 2020; 10(2):212-23. doi:10.1097/APO.0000000000000341.
doi: 10.1097/APO.0000000000000341
pmid: 33290287
|
[7] |
Watson PG, Young RD. Scleral structure, organization and disease: A review. Exp Eye Res 2004; 78(3):609-23. doi:10.1016/s0014-4835(03)00212-4.
doi: 10.1016/s0014-4835(03)00212-4
pmid: 15106941
|
[8] |
Madanagopalan VG, Shivananda N, Krishnan T. Surgically induced necrotizing scleritis after retinal detachment surgery masquerading as scleral abscess. GMS Ophthalmol Cases 2019; 9: Doc18. doi:10.3205/oc000107.
doi: 10.3205/oc000107
|
[9] |
Brandt O, Bircher AJ. Delayed-type hypersensitivity to oral and parenteral drugs. J Dtsch Dermatol Ges 2017Nov; 15(11):1111-32. doi:10.1111/ddg.13362.
doi: 10.1111/ddg.13362
pmid: 29106000
|
[10] |
O'Donoghue E, Lightman S, Tuft S, et al. Surgically induced necrotising sclerokeratitis (SINS) Fprecipitating factors and response to treatment. Br J Ophthalmol 1992; 76(1): 17-21. doi:10.1136/bjo.76.1.17.
doi: 10.1136/bjo.76.1.17
|
[11] |
Morley AM, Pavesio C. Surgically induced necrotising scleritis following three-port pars plana vitrectomy without scleral buckling: a series of three cases. Eye (Lond) 2008 Jan; 22(1):162-4. doi:10.1038/sj.eye.6702708.
doi: 10.1038/sj.eye.6702708
pmid: 17304259
|
[12] |
Young RD, Powell J, Watson PG. Ultrastructural changes in scleral proteoglycans precede destruction of the collagen fibril matrix in necrotizing scleritis. Histopathol 1988; 12(1): 75-84. doi:10.1111/j.1365-2559.1988.tb01918.x.
doi: 10.1111/j.1365-2559.1988.tb01918.x
|
[13] |
Riley GP, Harrall RL, Hazleman BL, et al. Collagenase (MMP1) and (TIMP) in destructive corneal diseaseassociated with rheumatoid arthritis. Eye (Lond) 1995; 9 (Pt 6):703-18. doi:10.1038/eye.1995.182.
doi: 10.1038/eye.1995.182
|
[14] |
Di Girolamo N, Lloyd A, McCluskey P, et al. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Am J Pathol 1997; 150(2): 653-66.
pmid: 9033278
|
[15] |
Di Girolamo N, McCluskey PJ, Lloyd A, et al. Localisation of stromelysin matrix metalloproteinase-3 and tissue inhibitor of metallo- proteinase TIMP-1 mRNA in scleritis. Ocul Immunol Inflamm 1995; 3(3): 181-94. doi:10.3109/09273949509069111.
doi: 10.3109/09273949509069111
pmid: 22823240
|
[16] |
Axmann S, Ebneter A, Zinkernagel MS. Imaging of the sclera in patients with scleritis and episcleritis using anterior segment optical coherence tomography. Ocul Immunol Inflamm 2016; 24(1):29-34. doi:10.3109/09273948.2015.1025983.
doi: 10.3109/09273948.2015.1025983
pmid: 26259046
|
[17] |
Diogo MC, Jager MJ, Ferreira TA. CT and MR imaging in the diagnosis of scleritis. AJNR Am J Neuroradiol 2016; 37(12):2334-9. doi:10.3174/ajnr.A4890.
doi: 10.3174/ajnr.A4890
|
[18] |
Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology 2012; 119:51-8. doi:10.1016/j.ophtha.2011.07.043.
doi: 10.1016/j.ophtha.2011.07.043
pmid: 22015381
|
[19] |
Ozzello DJ, Kolfenbach JR, Palestine AG. Uveitis specialists and rheumatologists select different therapies for idiopathic nonnecrotizing anterior scleritis. Ophthalmol Ther 2016; 5(2):245-52. doi:10.1007/s40123-016-0067-1.
doi: 10.1007/s40123-016-0067-1
pmid: 27744531
|
[20] |
Rathinam SR, Gonzales JA, Thundikandy R, et al. Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis. JAMA 2019; 322(10): 936-45. doi:10.1001/jama.2019.12618.
doi: 10.1001/jama.2019.12618
pmid: 31503307
|
[21] |
Jeon HS, Hyon JY, Kim MK, et al. Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea. Br J Ophthalmol 2016; 100(8):1066 - 70. doi:10.1136/bjophthalmol-2015-307462.
doi: 10.1136/bjophthalmol-2015-307462
pmid: 26598577
|
[22] |
Sharma SM, Damato E, Hinchcliffe AE, et al. Long-term efficacy and tolerability of TNF-alpha inhibitors in the treatment of noninfectious ocular inflammation: an 8-year prospective surveillance study. Br J Ophthalmol 2019; 105(9):1256-62. doi:10.1136/bjophthalmol-2018-312767.
doi: 10.1136/bjophthalmol-2018-312767
|
[23] |
Fabiani C, Sota J, Sainz de la Maza M, et al. Effectiveness of TNF-alpha blockade in the treatment of refractory noninfectious scleritis: a multicenter study. Clin Exp Rheumatol 2020; 38(6):1138-44.
|
[24] |
Ramirez-Ortiz MA, Vasquez-Resendis A. Isolated bilateral posterior scleritis after eye trauma. J AAPOS 2007; 11(3), 284-5. doi:10.1016/j.jaapos.2006.09.019.
doi: 10.1016/j.jaapos.2006.09.019
pmid: 17257871
|
[25] |
Cho YH, Jung J, Lee KH, et al. Clinical features of patients with Behçet's disease and epididymitis. J Urol 2003; 170 (4 Pt 1):1231-3. doi:10.1097/01.ju.0000081957.90395.4c.
doi: 10.1097/01.ju.0000081957.90395.4c
|